Maternal Obesity Associated With Higher Risk for Stillbirth Maternal Obesity Associated With Higher Risk for Stillbirth
Findings from a large cohort study suggested that early delivery could reduce the risk for stillbirth in patients with obesity.Medscape Medical News (Source: Medscape Internal Medicine Headlines)
Source: Medscape Internal Medicine Headlines - March 11, 2024 Category: Internal Medicine Tags: Diabetes & Endocrinology Source Type: news
The banyan tree of health: Combating the titan twindemic of diabetes and obesity
The twindemic of type 2 diabetes and obesity is a major challenge in India, with over 100 million adults living with diabetes and roughly 250 million adults being overweight or obese. (Source: The Economic Times)
Source: The Economic Times - March 11, 2024 Category: Consumer Health News Source Type: news
Kids Whose Parents Have Obesity More Likely to Be Obese Kids Whose Parents Have Obesity More Likely to Be Obese
Having parents with obesity in middle age raises a child ' s risk for obesity at a similar age sixfold shows data on how obesity affects different generations in one family.Medscape Medical News (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - March 11, 2024 Category: Endocrinology Tags: Diabetes & Endocrinology Source Type: news
Kids Whose Parents Have Obesity More Likely to Have Obesity Kids Whose Parents Have Obesity More Likely to Have Obesity
Having parents with obesity in middle age raises a child ' s risk for obesity at a similar age sixfold shows data on how obesity affects different generations in one family.Medscape Medical News (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - March 11, 2024 Category: Endocrinology Tags: Diabetes & Endocrinology Source Type: news
Exercise Linked to Lower Kidney Disease Risk in Diabetes Exercise Linked to Lower Kidney Disease Risk in Diabetes
Higher weekly levels of moderate physical activity were linked to proportionally lower risks for CKD in adults with T2D and obesity or overweight, a new study showed.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - March 11, 2024 Category: Consumer Health News Tags: Diabetes & Endocrinology Source Type: news
Obesity Drugs 2024: The Skinny on the Top 3 Weight-Loss Stocks
The catalyst for top weight-loss stocks comes down to one sweeping attribute: a burgeoning total addressable market. According to a Goldman Sachs analysis, earlier last year, the global industry for anti-obesity medications (AOMs) reached $6 billion on an annualized basis. By 2030, the sector…#goldmansachs #novonordisk #nvo #novonordisks #amycretin #novo #wegovy #amgen #amgn #easily (Source: Reuters: Health)
Source: Reuters: Health - March 10, 2024 Category: Consumer Health News Source Type: news
3 Millionaire-Maker Technology Stocks Worth a Closer Look
If your ultimate investing goal is becoming a millionaire, there's one sector you'll want to overweight within your portfolio: Technology. The tech sector's stocks have a long history of outperforming the overall market. That's because tech companies tend to introduce the world's most…#nvidia #intel #snapdragon #cpu #cristianoamon #android #palantirtechnologies #usarmy #contractingcommand #precedenceresearch (Source: Reuters: Health)
Source: Reuters: Health - March 10, 2024 Category: Consumer Health News Source Type: news
Is Novo Nordisk a Buy After Its New Obesity Candidate's Success in a Clinical Trial?
Shares of Novo Nordisk (NYSE: NVO) rose to a new all-time high on Thursday, March 7. The market was responding to encouraging results from a clinical trial with an experimental weight-management drug called amycretin. Amycretin is an orally available treatment candidate, which could give it a big…#novonordisk #nvo #amycretin #wegovyand #elililly #lly #glp1 #wegovyandozempic #amylin #cagrisema (Source: Reuters: Health)
Source: Reuters: Health - March 10, 2024 Category: Consumer Health News Source Type: news
The Best Stocks to Invest $50,000 in Right Now
If you're planning to invest a considerable sum in the stock market, take a look at the following businesses first. These elite enterprises are proven wealth builders, and their stocks are all smart buys today. If you're searching for a low-risk way to profit from the growth of artificial…#msft #openai #excel #obese #elililly #lly #zepbound #yahoo #costcowholesale #cost (Source: Reuters: Health)
Source: Reuters: Health - March 10, 2024 Category: Consumer Health News Source Type: news
Eli Lilly's campaign seeks to resolve weight-loss drug misconceptions
Pharmaceutical giant Eli Lilly and Company is trying to clear up misconceptions about obesity care as it increases investment in its highly popular weight-loss drugs. With the latest phase of Lilly's "Get Better" campaign, the company aims to focus the importance of obesity treatment as a disease,…#elilillyandcompany #lilly #elonmusk #fda #bignight #shame #novo #wegovyandozempic #elililly #lillydirect (Source: Reuters: Health)
Source: Reuters: Health - March 9, 2024 Category: Consumer Health News Source Type: news
The Top 3 Pharma Stocks to Buy in March2024
Discover the top three pharma stocks ready to soar in 2024's booming market Investors’ eyes are closely following the massive rally in pharmaceutical stocks amid the red-hot anti-obesity market. In 2024, the projected revenue for the pharma market is estimated to reach $1.15 trillion. And,…#goldmansachsresearch #elililly #lly #eps #yoy #mounjaro #elilillys #bankofamerica #denmark #novonordisk (Source: Reuters: Health)
Source: Reuters: Health - March 9, 2024 Category: Consumer Health News Source Type: news
FDA approves Wegovy for lowering heart attack and stroke risk in overweight patients
The popular weight-loss drug Wegovy, which has helped millions of Americans shed pounds, can now be used to reduce the risk of stroke, heart attacks and other serious cardiovascular problems in patients who are…#fda #novonordisk #wegovy #johnsharretts #marthagulati #ozempic #medicare #tricianeuman #kff #ahip (Source: Reuters: Health)
Source: Reuters: Health - March 9, 2024 Category: Consumer Health News Source Type: news
Obesity drug Wegovy is approved to cut heart attack and stroke risk in overweight patients
The popular weight-loss drug Wegovy can now be used to reduce the risk of stroke, heart attacks and other serious heart problems in patients who are overweight or who have obesity (Source: ABC News: Health)
Source: ABC News: Health - March 8, 2024 Category: Consumer Health News Tags: Health Source Type: news
Wegovy Is Good for More Than Just Weight Loss
The obesity drug Wegovy can now claim to lower the risk of heart attack, stroke, and other cardiovascular issues in people who are overweight or who have obesity, and also have cardiovascular disease. It’s the first weight-loss drug to carry an indication for heart benefits.
The U.S. Food and Drug Administration (FDA) approved the addition to the label on March 8 based on a study from Wegovy’s manufacturer, Novo Nordisk, showing that the drug lowered the risk of heart attack, stroke, or dying of heart-related issues in this population by 20% compared to people receiving placebo.
[time-brightcove not-tgx=...
Source: TIME: Health - March 8, 2024 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized healthscienceclimate Source Type: news
FDA Approves Wegovy to Lower Risk for CVD Events in Patients With Obesity
FRIDAY, March 8, 2024 -- The U.S. Food and Drug Administration has approved Wegovy (semaglutide) for the prevention of myocardial infarction, stroke, and cardiovascular death in patients with obesity or overweight.
In one multinational study... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - March 8, 2024 Category: Pharmaceuticals Source Type: news
